Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2017 Sep 2

PMID 28862939

Citations 23

Authors

Toshiyasu Ogata

Ryu Matsuo

Fumi Kiyuna

Jun Hata

Tetsuro Ago

Yoshio Tsuboi

Takanari Kitazono

Masahiro Kamouchi

Affiliations

Soon will be listed here.

Abstract

Background: Among patients with ischemic stroke and atrial fibrillation, which ones are at high risk of recurrent stroke is unclear. This study aimed to determine whether left atrial size was associated with long-term risk of stroke recurrence in patients with nonvalvular atrial fibrillation.

Methods And Results: In this multicenter prospective cohort study, nonvalvular atrial fibrillation patients hospitalized for acute ischemic stroke were enrolled and followed up after discharge. Indexed-left atrial diameter was obtained by dividing left atrial diameter by body surface area. Cause-specific and subdistribution hazard ratios of recurrent stroke were estimated by Cox proportional hazards and Fine-Gray models, respectively. Risk prediction was evaluated by integrated discrimination improvement and net reclassification improvement. In total, 1611 patients (77.8±10.2 [mean±SD] years, 44.5% female) were included. During follow-up for 2.40±1.63 (mean±SD) years, 251 patients had recurrent stroke and 514 patients died. An increased indexed-left atrial diameter (per 1 cm/m) was significantly associated with elevated risk of stroke recurrence (hazard ratio 1.60, 95% CI 1.30-1.98). The association was maintained when death was regarded as the competing risk and in 1464 patients who were treated with anticoagulants (hazard ratio 1.59, 95% CI 1.27-2.00). Risk prediction for recurrent stroke was significantly improved by adding indexed-left atrial diameter to the baseline model composed of the factors in the CHADS score or those in the CHADS-VASc score.

Conclusion: These findings suggest that left atrial enlargement is associated with an increased risk of recurrent stroke in nonvalvular atrial fibrillation patients with ischemic stroke.

Citing Articles

The usefulness of global longitudinal peak strain and left atrial volume index in predicting atrial fibrillation in patients with ischemic stroke.

Park S, Kim Y, Lee M, Lee S, Bae J, Lee J Front Neurol. 2024; 14:1287609.

PMID: 38249733 PMC: 10797101. DOI: 10.3389/fneur.2023.1287609.

Left atrial enlargement and high uric acid level are risk factors for left atrial thrombus or dense spontaneous echo contrast in atrial fibrillation patients with low to moderate embolic risk assessed by CHADS-VAS score.

Tan C, Liu J, Zheng Y, Li Z, Zhou S Front Cardiovasc Med. 2023; 10:937770.

PMID: 37465453 PMC: 10351038. DOI: 10.3389/fcvm.2023.937770.

The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation.

Herlekar R, Sur Roy A, Hajiev S, Induruwa I, Agarwal S, Evans N Eur Stroke J. 2023; 8(2):541-548.

PMID: 37231697 PMC: 10334183. DOI: 10.1177/23969873231168367.

The effect of different preoperative left atrial appendage emptying speeds on left atrial function in patients with persistent atrial fibrillation after left atrial appendage closure combined with catheter ablation.

Yang C, Yang J, Liu Q, You L, Wu J, Zhang Y BMC Cardiovasc Disord. 2022; 22(1):399.

PMID: 36068492 PMC: 9450426. DOI: 10.1186/s12872-022-02842-z.

The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Silva Cunha P, Laranjo S, Heijman J, Oliveira M Front Cardiovasc Med. 2022; 9:879984.

PMID: 35859594 PMC: 9289204. DOI: 10.3389/fcvm.2022.879984.

References

. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med. 1992; 116(1):6-12. DOI: 10.7326/0003-4819-116-1-6. View

Ayirala S, Kumar S, OSullivan D, Silverman D . Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011; 24(5):499-505. DOI: 10.1016/j.echo.2011.02.010. View

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982-92. DOI: 10.1053/j.ajkd.2008.12.034. View

Hijazi Z, Oldgren J, Lindback J, Alexander J, Connolly S, Eikelboom J . The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016; 387(10035):2302-2311. DOI: 10.1016/S0140-6736(16)00741-8. View

Aronow W, Gutstein H, Hsieh F . Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol. 1989; 63(5):366-7. DOI: 10.1016/0002-9149(89)90349-4. View

Dickstein K, Cohen-Solal A, Filippatos G, McMurray J, Ponikowski P, Poole-Wilson P . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the.... Eur Heart J. 2008; 29(19):2388-442. DOI: 10.1093/eurheartj/ehn309. View

Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J . N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol. 2013; 61(22):2274-84. DOI: 10.1016/j.jacc.2012.11.082. View

Harrell Jr F, Lee K, Mark D . Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4):361-87. DOI: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4. View

Fujimoto S, Watanabe T, Sakamoto A, Yukawa K, Morimoto K . [Studies on the physical surface area of Japanese. 18. Calculation formulas in three stages over all ages]. Nihon Eiseigaku Zasshi. 1968; 23(5):443-50. DOI: 10.1265/jjh.23.443. View

10.

Pencina M, DAgostino Sr R, Steyerberg E . Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011; 30(1):11-21. PMC: 3341973. DOI: 10.1002/sim.4085. View

11.

Yaghi S, Moon Y, Mora-McLaughlin C, Willey J, Cheung K, Di Tullio M . Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015; 46(6):1488-93. PMC: 4442058. DOI: 10.1161/STROKEAHA.115.008711. View

12.

Leung D, Black I, Cranney G, Hopkins A, Walsh W . Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1994; 24(3):755-62. DOI: 10.1016/0735-1097(94)90025-6. View

13.

Hijazi Z, Lindback J, Alexander J, Hanna M, Held C, Hylek E . The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016; 37(20):1582-90. PMC: 4875560. DOI: 10.1093/eurheartj/ehw054. View

14.

Gage B, Waterman A, Shannon W, Boechler M, Rich M, Radford M . Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285(22):2864-70. DOI: 10.1001/jama.285.22.2864. View

15.

Lip G, Tse H, Lane D . Atrial fibrillation. Lancet. 2011; 379(9816):648-61. DOI: 10.1016/S0140-6736(11)61514-6. View

16.

Benjamin E, DAgostino R, Belanger A, Wolf P, Levy D . Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995; 92(4):835-41. DOI: 10.1161/01.cir.92.4.835. View

17.

Moulton A, Singer D, Haas J . Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med. 1991; 91(2):156-61. DOI: 10.1016/0002-9343(91)90008-l. View

18.

Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E . Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2014; 1(5):212-28. PMC: 4020724. DOI: 10.1111/j.2040-1124.2010.00074.x. View

19.

Oldgren J, Hijazi Z, Lindback J, Alexander J, Connolly S, Eikelboom J . Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation. 2016; 134(22):1697-1707. DOI: 10.1161/CIRCULATIONAHA.116.022802. View

20.

Laukkanen J, Kurl S, Eranen J, Huttunen M, Salonen J . Left atrium size and the risk of cardiovascular death in middle-aged men. Arch Intern Med. 2005; 165(15):1788-93. DOI: 10.1001/archinte.165.15.1788. View